Home » Topics » Regulatory

Regulatory
RSS

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

ESI Lederle launches generic acyclovir

April 29, 1997

FDA approves new labeling for Bristol-Myers Squibb's Pravachol

April 29, 1997

Mylan Laboratories's Acyclovir receives FDA approval

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...